Year-3 adherence and persistence research abstract Learn more about the methodology of Primes research study, GLP-1 Therapy to Treat Obesity Among Members Without Diabetes: Three-Year Persistence and Year-Over-Year Persistence Rate Change. Historical Adherence and persistence data Primes real-world, integrated data revealed further insights at Year 2, including that just 1 in 7 people remain on GLP-1 drugs for weight loss
The rates of invasive recurrence and metastatic disease were high in both groups, but the researchers found that people using GLP-1s had a 74% lower risk of invasive or metastatic cancer progression
doi: 10.1016/j.chom.2023.11.021 164 McGaviganA
BMI 30 or above no qualifying condition needed
Children with FAS benefit from behavioral and functional training, social skill training, and tutoring
And, if youre looking to exercise more, this supplement may be helpful